On May 5, 2026, the White House Office of National Drug Control Policy dropped a 195-page National Drug Control Strategy. Buried inside this document, alongside the standard alarm bells about fentanyl and ‘youth access,’ was an affirmation of the incoming federal recriminalization of hemp-derived THC products. High-potency marijuana got its own section of concern. The strategy invokes ‘convergent evidence’ linking cannabis to psychosis. The administration, in other words, is doing what the drug war apparatus always does — doubling down on failure.
The irony is so thick you could press it into a hemp brick. The United States has been running a real-world experiment in cannabis legalization for nearly a decade, and it went fine. Better than fine. And the Trump administration is choosing to look away from the data.
What the Experiment Actually Showed
Thanks to the 2018 Farm Bill, hemp-derived cannabinoids — Delta-8 THC, THCa, CBD, and a roster of others — became legally available in stores across nearly every state. This wasn’t some tightly regulated dispensary rollout. It was chaotic, unregulated, organic market growth. Gas stations. Head shops. Online delivery.
By 2024, this market had grown to an estimated $28 billion per year. Millions of Americans accessed psychoactive cannabis products. Youth usage did not spike in ways that exceeded pre-existing trends. The country did not descend into reefer madness. Society functioned. Tax revenue was generated. Jobs were created.
This is the data a smart politician would pick up and run with. Here’s a living proof-of-concept that Americans can access cannabis without the apocalypse. Here’s an argument for a clear federal framework that protects consumers, generates revenue, and stops law enforcement from wasting resources on flower.
Instead, the White House is calling it a loophole to close.
— — —
The Trump Brand and the Legalization Calculation
Let me be direct about something: as of writing this, Donald Trump is having one of the most catastrophic second terms in modern presidential history. The tariff chaos rattled markets globally. The Iran military posture has created more instability than it resolved. His approval ratings have tracked toward historical lows for an incumbent at this stage. The MAGA coalition, which includes a significant libertarian-leaning flank, is fractured.
Cannabis legalization polls above 70% support nationally. Among Republicans under 45, support for legalization consistently runs higher than party leadership acknowledges. A clear, decisive move toward federal cannabis reform — not the Schedule III half-measure that simply hands the market to pharmaceutical companies, but actual descheduling — would be a genuine populist win. It would generate tax revenue, deliver on the personal freedom rhetoric, and peel off voters who are currently looking for an exit.
Here’s the honest assessment though: I’m not sure it would save his brand at this point. When a president’s approval collapses, it’s rarely one issue that rebuilds it. Cannabis legalization would get two news cycles before the next crisis buried it. The damage done by the economic instability and foreign policy adventurism is structural. A weed win wouldn’t fix that.
But it would matter for the industry. It would matter for the millions of people still carrying criminal records for cannabis. It would matter for the hemp farmers now watching a $28 billion market get legislated out from under them. Whether Trump can personally recover from it is almost beside the point.
What the White House Strategy Gets Wrong
The ONDCP document raises ‘high potency marijuana’ as a primary concern, invoking comparisons to tobacco marketing and warnings about psychosis risk. These are real issues worth discussing seriously. High-potency concentrates marketed to young audiences are a legitimate regulatory challenge.
But here’s what the strategy gets backwards: an unregulated market produces those problems. A regulated market gives you tools to address them. Age verification, labeling requirements, potency disclosure, product standards — these are all things a federal regulatory framework could mandate. What prohibition produces instead is products sold out of unlabeled pouches by people with no accountability.
The White House is essentially saying: ‘This unregulated market has some problems, therefore let’s keep it unregulated — but illegal.’ That is not logic. That is the continuation of a policy that has never worked, dressed up in public health language.
The hemp industry didn’t create a regulatory nightmare. Congress and the FDA’s paralysis did. The 2018 Farm Bill created the legal space; the agencies responsible for filling that space with consumer protections failed to act. And now the same government that refused to regulate the market wants to criminalize it.
The Sticky Bottom Line
The Trump administration had an opening. The hemp market proved the concept. The polling supported the move. The fiscal argument was there. Instead, the White House published a 195-page document that reads like it was written in 1988, invokes psychosis studies with contested methodology, and affirms the recriminalization of a $28 billion industry that was, by any reasonable measure, working.
There’s still time to change course. Whether this administration has the strategic clarity to recognize the opportunity, let alone the political will to act on it, is another question entirely.
Don’t hold your breath. But don’t stop pushing, either.
TRUMP’S CANNABIS STATE-LEVEL CHANGES, READ ON…
